SIGNIFY HEALTH INC -CLASS A (SGFY) Fundamental Analysis & Valuation

NYSE:SGFY • US82671G1004

Current stock price

30.49 USD
+0.02 (+0.07%)
At close:
30.49 USD
0 (0%)
After Hours:

This SGFY fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

3

1. SGFY Profitability Analysis

1.1 Basic Checks

  • SGFY had negative earnings in the past year.
  • In the past year SGFY had a positive cash flow from operations.
SGFY Yearly Net Income VS EBIT VS OCF VS FCFSGFY Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 0 -200M -400M

1.2 Ratios

  • The profitability ratios for SGFY are negative, so there is not much use analyzing them.
  • SGFY has a better Return On Invested Capital (6.14%) than 67.26% of its industry peers.
Industry RankSector Rank
ROA N/A
ROE N/A
ROIC 6.14%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
SGFY Yearly ROA, ROE, ROICSGFY Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 0 -20 -40 -60 -80

1.3 Margins

  • With an excellent Operating Margin value of 13.53%, SGFY belongs to the best of the industry, outperforming 89.38% of the companies in the same industry.
  • SGFY's Operating Margin has improved in the last couple of years.
  • With a decent Gross Margin value of 45.33%, SGFY is doing good in the industry, outperforming 72.57% of the companies in the same industry.
  • In the last couple of years the Gross Margin of SGFY has declined.
Industry RankSector Rank
OM 13.53%
PM (TTM) N/A
GM 45.33%
OM growth 3Y50.3%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.69%
GM growth 5YN/A
SGFY Yearly Profit, Operating, Gross MarginsSGFY Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 0 20 -20 40 -40 -60

4

2. SGFY Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), SGFY is destroying value.
  • Compared to 1 year ago, SGFY has more shares outstanding
  • The debt/assets ratio for SGFY is higher compared to a year ago.
SGFY Yearly Shares OutstandingSGFY Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 50M 100M 150M 200M
SGFY Yearly Total Debt VS Total AssetsSGFY Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 500M 1B 1.5B 2B

2.2 Solvency

  • An Altman-Z score of 3.36 indicates that SGFY is not in any danger for bankruptcy at the moment.
  • The Altman-Z score of SGFY (3.36) is better than 76.99% of its industry peers.
  • SGFY has a debt to FCF ratio of 93.50. This is a negative value and a sign of low solvency as SGFY would need 93.50 years to pay back of all of its debts.
  • SGFY has a Debt to FCF ratio (93.50) which is in line with its industry peers.
  • SGFY has a Debt/Equity ratio of 0.53. This is a neutral value indicating SGFY is somewhat dependend on debt financing.
  • SGFY has a better Debt to Equity ratio (0.53) than 60.18% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.53
Debt/FCF 93.5
Altman-Z 3.36
ROIC/WACC0.66
WACC9.37%
SGFY Yearly LT Debt VS Equity VS FCFSGFY Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 200M 400M 600M 800M 1B

2.3 Liquidity

  • SGFY has a Current Ratio of 1.62. This is a normal value and indicates that SGFY is financially healthy and should not expect problems in meeting its short term obligations.
  • SGFY has a Current ratio of 1.62. This is in the better half of the industry: SGFY outperforms 67.26% of its industry peers.
  • A Quick Ratio of 1.62 indicates that SGFY should not have too much problems paying its short term obligations.
  • The Quick ratio of SGFY (1.62) is better than 72.57% of its industry peers.
Industry RankSector Rank
Current Ratio 1.62
Quick Ratio 1.62
SGFY Yearly Current Assets VS Current LiabilitesSGFY Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 200M 400M 600M 800M 1B

5

3. SGFY Growth Analysis

3.1 Past

  • The earnings per share for SGFY have decreased strongly by -390.91% in the last year.
  • The Revenue has grown by 23.33% in the past year. This is a very strong growth!
  • SGFY shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 17.09% yearly.
EPS 1Y (TTM)-390.91%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-253.85%
Revenue 1Y (TTM)23.33%
Revenue growth 3Y17.09%
Revenue growth 5YN/A
Sales Q2Q%232.24%

3.2 Future

  • The Earnings Per Share is expected to grow by 93.52% on average over the next years. This is a very strong growth
  • SGFY is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 18.33% yearly.
EPS Next Y200.72%
EPS Next 2Y93.52%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year13.26%
Revenue Next 2Y15.48%
Revenue Next 3Y18.86%
Revenue Next 5Y18.33%

3.3 Evolution

  • The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
SGFY Yearly Revenue VS EstimatesSGFY Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 1B 2B 3B
SGFY Yearly EPS VS EstimatesSGFY Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 0 -1 -2

3

4. SGFY Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for SGFY. In the last year negative earnings were reported.
  • SGFY is valuated quite expensively with a Price/Forward Earnings ratio of 94.60.
  • SGFY's Price/Forward Earnings is on the same level as the industry average.
  • SGFY's Price/Forward Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 22.19.
Industry RankSector Rank
PE N/A
Fwd PE 94.6
SGFY Price Earnings VS Forward Price EarningsSGFY Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 50 -50

4.2 Price Multiples

  • SGFY's Enterprise Value to EBITDA ratio is in line with the industry average.
  • SGFY's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 1516.44
EV/EBITDA 32.74
SGFY Per share dataSGFY EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3 4

4.3 Compensation for Growth

  • SGFY's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • SGFY's earnings are expected to grow with 93.52% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y93.52%
EPS Next 3YN/A

2

5. SGFY Dividend Analysis

5.1 Amount

  • SGFY has a Yearly Dividend Yield of 1.26%.
  • SGFY's Dividend Yield is rather good when compared to the industry average which is at 0.50. SGFY pays more dividend than 85.84% of the companies in the same industry.
  • Compared to the average S&P500 Dividend Yield of 1.89, SGFY is paying slightly less dividend.
Industry RankSector Rank
Dividend Yield 1.26%

5.2 History

  • SGFY does not have a reliable dividend history as it only pays dividend since a couple or years.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

DPN/A
EPS Next 2Y93.52%
EPS Next 3YN/A
SGFY Yearly Income VS Free CF VS DividendSGFY Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2018 2019 2020 2021 2022 0 -200M -400M

SGFY Fundamentals: All Metrics, Ratios and Statistics

SIGNIFY HEALTH INC -CLASS A

NYSE:SGFY (3/28/2023, 8:04:01 PM)

After market: 30.49 0 (0%)

30.49

+0.02 (+0.07%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)03-07
Earnings (Next)05-02
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners4.46%
Ins Owner Change0%
Market Cap5.46B
Revenue(TTM)805.50M
Net Income(TTM)-576.80M
Analysts70
Price Target30.01 (-1.57%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.26%
Yearly Dividend0.3
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-788.65%
Min EPS beat(2)-1114.2%
Max EPS beat(2)-463.11%
EPS beat(4)1
Avg EPS beat(4)-261.16%
Min EPS beat(4)-1114.2%
Max EPS beat(4)761.79%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-26.89%
Min Revenue beat(2)-42.43%
Max Revenue beat(2)-11.35%
Revenue beat(4)0
Avg Revenue beat(4)-14.07%
Min Revenue beat(4)-42.43%
Max Revenue beat(4)-0.2%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-51.79%
EPS NY rev (1m)0%
EPS NY rev (3m)-45.52%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.81%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-1.51%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 94.6
P/S 6.78
P/FCF 1516.44
P/OCF 171.13
P/B 8.7
P/tB N/A
EV/EBITDA 32.74
EPS(TTM)-0.32
EYN/A
EPS(NY)0.32
Fwd EY1.06%
FCF(TTM)0.02
FCFY0.07%
OCF(TTM)0.18
OCFY0.58%
SpS4.5
BVpS3.5
TBVpS-0.9
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA N/A
ROE N/A
ROCE N/A
ROIC 6.14%
ROICexc 9.77%
ROICexgc N/A
OM 13.53%
PM (TTM) N/A
GM 45.33%
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)5.48%
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3Y104.84%
ROICexc growth 5YN/A
OM growth 3Y50.3%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.69%
GM growth 5YN/A
F-Score3
Asset Turnover0.46
Health
Industry RankSector Rank
Debt/Equity 0.53
Debt/FCF 93.5
Debt/EBITDA 2.07
Cap/Depr 52.6%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.62
Quick Ratio 1.62
Altman-Z 3.36
F-Score3
WACC9.37%
ROIC/WACC0.66
Cap/Depr(3y)53.08%
Cap/Depr(5y)45.67%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-390.91%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-253.85%
EPS Next Y200.72%
EPS Next 2Y93.52%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)23.33%
Revenue growth 3Y17.09%
Revenue growth 5YN/A
Sales Q2Q%232.24%
Revenue Next Year13.26%
Revenue Next 2Y15.48%
Revenue Next 3Y18.86%
Revenue Next 5Y18.33%
EBIT growth 1Y26.74%
EBIT growth 3Y75.98%
EBIT growth 5YN/A
EBIT Next Year153.12%
EBIT Next 3Y41%
EBIT Next 5Y25.5%
FCF growth 1Y-96.67%
FCF growth 3Y-39.43%
FCF growth 5YN/A
OCF growth 1Y-75.44%
OCF growth 3Y-8.54%
OCF growth 5YN/A

SIGNIFY HEALTH INC -CLASS A / SGFY Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for SIGNIFY HEALTH INC -CLASS A?

ChartMill assigns a fundamental rating of 4 / 10 to SGFY.


Can you provide the valuation status for SIGNIFY HEALTH INC -CLASS A?

ChartMill assigns a valuation rating of 3 / 10 to SIGNIFY HEALTH INC -CLASS A (SGFY). This can be considered as Overvalued.


What is the profitability of SGFY stock?

SIGNIFY HEALTH INC -CLASS A (SGFY) has a profitability rating of 1 / 10.


Can you provide the financial health for SGFY stock?

The financial health rating of SIGNIFY HEALTH INC -CLASS A (SGFY) is 6 / 10.